Healwell AI Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 5/6

Healwell AI şirketinin toplam hissedar öz sermayesi CA$63.2M ve toplam borcu CA$15.0M olup, bu da borç-öz sermaye oranını 23.8% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla CA$93.4M ve CA$30.2M dir.

Anahtar bilgiler

23.8%

Borç/özkaynak oranı

CA$15.02m

Borç

Faiz karşılama oranı	n/a
Nakit	CA$19.82m
Eşitlik	CA$63.17m
Toplam yükümlülükler	CA$30.21m
Toplam varlıklar	CA$93.38m

Son finansal sağlık güncellemeleri

Güncelleme yok

Recent updates

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: 6H90 'nin kısa vadeli varlıkları ( CA$36.3M ) kısa vadeli yükümlülüklerini ( CA$12.7M ) aşıyor.

Uzun Vadeli Yükümlülükler: 6H90 şirketinin kısa vadeli varlıkları ( CA$36.3M ) uzun vadeli yükümlülüklerini ( CA$17.5M ) aşmaktadır.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: 6H90 şirketinin toplam borcundan daha fazla nakiti var.

Borcun Azaltılması: 6H90 'nin borç/öz sermaye oranı son 5 yılda 66.9% seviyesinden 23.8% seviyesine düştü.

Bilanço

Nakit Pist Analizi

Geçmişte ortalama olarak zarar eden şirketler için, en az 1 yıllık nakit akışına sahip olup olmadıklarını değerlendiriyoruz.

İstikrarlı Nakit Pisti: 6H90 şirketinin mevcut serbest nakit akışına göre bir yıldan az nakit akışı süresi bulunmaktadır.

Tahmini Nakit Akışı: 6H90 serbest nakit akışı her yıl % 50.4 1.2 yıl yetecek nakit akışına sahip olacaktır.

Healwell AI Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 5/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Recent updates

New minor risk - Financial position

Second quarter 2024 earnings released

Healwell AI Inc. to Report Q2, 2024 Results on Aug 12, 2024

Healwell AI Inc. (TSX:AIDX) acquired 20% stake in Mci Polyclinic Group Inc.

Healwell AI Inc. (TSX:AIDX) completed the acquisition of VeroSource Solutions Inc.

Healwell AI Inc. (TSX:AIDX) agreed to acquire 100% stake in Bio Pharma Services Inc. from Think Research Corporation for CAD 14.4 million.

Healwell AI Inc. (TSX:AIDX) agreed to acquire 100% stake in Bio Pharma Services Inc. from Think Research Corporation for CAD 14.4 million.

Healwell AI Inc. (TSX:AIDX) agreed to acquire VeroSource Solutions Inc. for CAD 24.5 million on June 11, 2024.

Healwell AI Inc. Announces Chief Financial Officer Changes

Healwell AI Inc. announced that it has received CAD 20.00025 million in funding

First quarter 2024 earnings released: CA$0.06 loss per share (vs CA$0.14 loss in 1Q 2023)

Healwell AI Inc. to Report Q1, 2024 Results on May 14, 2024

Healwell AI Inc. announced that it expects to receive CAD 16.000065 million in funding

Healwell AI Inc., Annual General Meeting, Jun 25, 2024

Healwell AI Inc., Annual General Meeting, Jun 12, 2024

Full year 2023 earnings released: CA$0.56 loss per share (vs CA$0.42 loss in FY 2022)

Healwell AI Inc. to Report Q4, 2023 Results on Mar 28, 2024

Healwell AI Inc. Announces Executive Changes

Healwell AI Inc. (TSX:AIDX) completed the acquisition of Intrahealth Systems Limited from WELL Health Technologies Corp. (TSX:WELL) for approximately $24.2 million.

Healwell AI Inc. (TSX:AIDX) completed the acquisition of Intrahealth Systems Limited from WELL Health Technologies Corp. (TSX:WELL) for approximately $24.2 million.

Healwell AI Inc. (TSX:AIDX) entered into an agreement to acquire Intrahealth Systems Limited from WELL Health Technologies Corp. (TSX:WELL) for approximately $24.2 million.

New major risk - Shareholder dilution

Healwell AI Inc. has completed a Composite Units Offering.

Healwell AI Inc. (TSX:AIDX) completed the acquisition of an unknown majority stake in Pentavere Research Group Inc. Christopher Pettengell, Aviva Pratzer, Mark Harris, Steven Aviv, Hilton Silberg, AAron Leibtag and others.

Healwell AI Inc. (TSX:AIDX) entered into an agreement to acquire an unknown stake in Pentavere Research Group Inc. for CAD 5.9 million.

Third quarter 2023 earnings released: CA$0.14 loss per share (vs CA$0.18 loss in 3Q 2022)

Healwell Ai Inc. Appoints Mark Findlay as Senior Vice President of Sales and Marketing for Canada

Healwell AI Inc. to Report Q3, 2023 Results on Nov 15, 2023

Healwell AI Inc. announced that it has received CAD 3.00024 million in funding

Less than half of directors are independent

Healwell Al Inc. Announces Board and Executive Changes

High number of new and inexperienced directors

MCI Onehealth Technologies Inc. Announces Sven Grail and George Christodoulou, the Former Co-Chairs, Did Not Stand for Re-Election

New major risk - Negative shareholders equity

Second quarter 2023 earnings released: CA$0.21 loss per share (vs CA$0.084 loss in 2Q 2022)

MCI Onehealth Technologies Inc., Annual General Meeting, Sep 21, 2023

WELL Health Technologies Corp. (TSX:WELL) completed the acquisition of MCI Medical Clinics (Alberta) Inc. from MCI Onehealth Technologies Inc. (TSX:DRDR).

WELL Health Technologies Corp. (TSX:WELL) entered into a definitive share purchase agreement to acquire MCI Medical Clinics (Alberta) Inc. from MCI Onehealth Technologies Inc. (TSX:DRDR) for CAD 2 million.

MCI Onehealth Technologies Inc. announced that it has received CAD 1.5 million in funding

First quarter 2023 earnings released: CA$0.15 loss per share (vs CA$0.086 loss in 1Q 2022)

MCI Onehealth Technologies Inc. Announces Changes to Management Team Structure

High number of new and inexperienced directors

MCI Onehealth Technologies Inc. to Report Q3, 2022 Results on Nov 14, 2022

MCI Onehealth Technologies Inc. Expands Data Insights Offering with Innovative AI-driven Continuing Medical Education

Second quarter 2022 earnings released: CA$0.084 loss per share (vs CA$0.058 loss in 2Q 2021)

MCI Onehealth Technologies Inc. to Report Q2, 2022 Results on Aug 15, 2022

MCI Onehealth Technologies Inc. Provides Revenue Guidance for the Year 2022

First quarter 2022 earnings released: CA$0.084 loss per share (vs CA$0.054 loss in 1Q 2021)

MCI Onehealth Technologies Inc. to Report Q1, 2022 Results on May 16, 2022

Less than half of directors are independent

MCI Onehealth Technologies Inc., Annual General Meeting, Jun 17, 2022

Full year 2021 earnings released: CA$0.33 loss per share (vs CA$0.027 loss in FY 2020)

MCI Onehealth Technologies Inc. Provides Revenue Guidance for Fiscal 2022

MCI Onehealth Appoints Jennifer Foster as Chief Operating Officer with Mandate to Support Expansion of Tech and Data Offerings

Third quarter 2021 earnings released: CA$0.11 loss per share

Co-Founder & Co-Executive Chair recently bought €58k worth of stock

Second quarter 2021 earnings released

MCI Onehealth Technologies Inc. (TSX:DRDR) acquired a 9% stake in ReGen Scientific Inc.

Finansal Durum Analizi

Borç-Özkaynak Tarihçesi ve Analizi

Bilanço

Nakit Pist Analizi

Sağlıklı şirketleri keşfedin